Nasmed Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-10-2024
- Paid Up Capital ₹ 0.10 M
as on 29-10-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.75 Cr
as on 29-10-2024
- Revenue %
(FY 2023)
- Net Worth -21483.38%
(FY 2023)
- Total Assets 489.66%
(FY 2023)
About Nasmed Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹14.75 Cr.
Sandip Shah, Bhavini Shah, Kiran Thakore, and Three other members serve as directors at the Company.
- CIN/LLPIN
U33209GJ2022PTC129341
- Company No.
129341
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nasmed Diagnostic Private Limited offer?
Nasmed Diagnostic Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Vials and Ampoules.
Who are the key members and board of directors at Nasmed Diagnostic?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suril Shah  | Director | 12-Feb-2022 | Current |
| Bhavini Shah | Additional Director | 08-May-2024 | Current |
| Sandip Shah | Director | 12-Feb-2022 | Current |
| Kiran Thakore | Additional Director | 21-Mar-2022 | Current |
| Tapan Mehta | Additional Director | 08-Jun-2022 | Current |
Kush Patel  | Additional Director | 10-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Nasmed Diagnostic.
Nasmed Diagnostic Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 21483.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nasmed Diagnostic?
Unlock access to Nasmed Diagnostic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Neuberg Supratech Rajkot Private LimitedActive 6 years 3 monthsSandip Shah and Bhavini Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 May 2022 | ₹14.75 Cr | Open |
How Many Employees Work at Nasmed Diagnostic?
Nasmed Diagnostic has a workforce of 24 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nasmed Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nasmed Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
